In vitro models of vasculogenesis and angiogenesis

Laboratory Investigation

Volumn 81, Issue 4, 2001, Pages 439-452

  Vailhe B ^a   Vittet, D ^a   Feige, J J ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; CELL CULTURE; CULTURE MEDIUM; EMBRYO; EMBRYO CELL; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; STEM CELL;

EID: 0035044630     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780252     Document Type: Short Survey

References (149)

1. The thrombospondin type 1 repeat (TSR) superfamily: Diverse proteins with related roles in neuronal development
2. Growth factors reverse the impaired sprouting of microvessels from aged mice
3. 2
4. Angiogenesis inhibition: A review
5. VE-Cadherin mediates endothelial cell capillary-tube formation in fibrin and collagen gels
6. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins
7. Development of endothelial cell lines from embryonic stem cells: A tool for studying genetically manipulated endothelial cells in vitro
8. Angiogenesis: Characterization of a cellular model
9. Microvascular endothelial cells from adrenal medulla: A model for in vitro angiogenesis
10. In vitro model of angiogenesis using a human endothelium-derived permanent cell line: Contributions of induced gene expression, G-proteins, and integrins
11. Characterization of the vasculogenic block in the absence of vascular endothelial growth factor-A
12. RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the αv/β3 and α4/β1 integrins
13. Vascular development: Cellular and molecular regulation
14. AAMP, a conserved protein with immunoglobulin and WD40 domains, regulates endothelial tube formation in vitro
15. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF
16. Erythropoiesis and vasculogenesis in embryoid bodies lacking visceral yolk sac endoderm
17. Leptin, the product of Ob gene, promotes angiogenesis
18. Requirement of vascular integrin αv/β3 for angiogenesis
19. Integrin αv/β3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
20. Anti-integrin αv/β3 blocks human breast cancer growth and angiogenesis in human skin
21. The hemostatic system as a regulator of angiogenesis
22. A novel in vitro assy for human angiogenesis
23. Mechanisms of angiogenesis and arteriogenesis
24. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
25. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
26. Fibrin II induces endothelial cell capillary tube formation
27. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD
28. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
29. Regulation of endothelial cell morphogenesis by integrins, mechanical forces, and matrix guidance pathways
30. An α2/β1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix
31. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells
32. Involvement of endothelial PECAM-1/CD31 in angiogenesis
33. Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis
34. The in vitro development of blastocyst-derived cell lines: Formation of visceral yolk sac, blood islands and mycardium
35. Perturbations in the fibrinolytic pathway abolish cyst formation but not capillary-like organization of cultured murine endothelial cells
36. The formation of capillary-like tubes by calf aortic endothelial cells grown in vitro
37. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
38. Modelling biological gel contraction by cells: Mechanocellular formulation and cell traction force quantification
39. A new model of vasculogenesis and angiogenesis in vitro as compared with vascular growth in the avian area vasculosa
40. Induction of vasculogenesis and hematopoiesis in vitro
41. Angiogenesis in cancer, vascular, rheumatoid and other disease
42. Angiogenesis in vitro
43. Angiogenesis
44. Role of the flt-1 receptor tyrosine kinase in regulating the assembly of the vascular endothelium
45. Regulation of in vitro capillary tube formation by anti-integrin antibodies
46. Microvascular endothelial cells from E-selectin-deficient mice form tubes in vitro
47. Role of vascular endothelial-cadherin in vascular morphogenesis
48. Transforming growth factor-β signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice
49. Inhibitors of basement membrane collagen synthesis prevent endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo
50. Formation of endothelial cell networks
51. Expression and inducibility of vascular adhesion receptors in development
52. Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis
53. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
54. Angiogenic potential of microvessels fragments established in three-dimensional collagen gels
55. Effects of basic fibroblast growth factor on human microvessel endothelial cell migration on collagen I correlates inversely with adhesion and is cell density dependent
56. Functional characterization of the spontaneously transformed human umbilical vein endothelial cell line ECV304: Use in an in vitro model of angiogenesis
57. How does extracellular matrix control capillary morphogenesis?
58. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: Role of extracellular matrix
59. Angiogenesis: A dynamic balance of stimulators and inhibitors
60. Differential expression of extracellular proteins is correlated with angiogenesis in vitro
61. Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF-beta 1
62. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
63. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells
64. Quantitative angiogenesis assays: Progress and problems
65. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
66. Gene expression profiling in an in vitro model of angiogenesis
67. Antiangiogenic agents
68. Angiopoietin-1 induces sprouting angiogenesis in vitro
69. Cooperative effect of TNFα, bFGF and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity
70. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation
71. Tensional forces in fibrillar extracellular matrices control directional capillary sprouting
72. Induction of vasculogenesis in quail blastodisc-derived embryoid bodies
73. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices
74. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures
75. Reorganization of endothelial cord-like structures on basement membrane complex (Matrigel): Involvement of transforming growth factor β1
76. Induction of apoptotic cell death in vascular endothelial cells cultured in three-dimensional collagen lattice
77. Blockage of urokinase receptor reduces in vitro the motility and the deformability of endothelial cells
78. Organizational behavior of human umbilical vein endothelial cells
79. Phenotypic modulation of endothelial cells by transforming growth factor-β depends upon the composition and organization of the extracellular matrix
80. Capillary endothelial cell cultures: Phenotypic modulation by matrix components
81. A mechanical model for the formation of vascular networks in vitro
82. Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin
83. Vascular outgrowths from tissue explants embedded in fibrin or collagen gels: A simple in vitro model of angiogenesis
84. Tumor-promoting phorbol esters induce angiogenesis in vitro
85. In vitro rapid organization of endothelial cells into capillary-like network is promoted by collagen matrices
86. Three-dimensional in vitro assay of endothelial cell invasion and capillary tube morphogenesis
87. Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors
88. Basic fibroblast growth factor induces angiogenesis in vitro
89. The role of growth factors and extracellular matrix in angiogenesis and epithelial morphogenesis
90. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model
91. A novel, microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis
92. A microcarrier-based cocultivation system for the investigation of factors and cells involved in angiogenesis in three-dimensional fibrin matrices in vitro
93. The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration
94. The microvascular extracellular matrix. Developmental changes during angiogenesis in the aortic ring-plasma clot model
95. Growth of microvessels in serum-free matrix culture of rat aorta
96. Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: A comparative study of angiogenesis in Matrigel, collagen, fibrin, and plasma clot
97. Histotypic angiogenesis in vitro: Light microscopic, ultrastructural, and radioautographic studies
98. Interactions between newly formed endothelial channels and carcinoma cells in plasma clot cultures
99. Automatic vessel segmentation and quantification of the rat aortic ring assay of angiogenesis
100. Fibrin-enhanced endothelial cell organisation
101. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells
102. An in vitro model for the study of human bone marrow angiogenesis: Role of hematopoietic cytokines
103. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro
104. Angiogenesis: A paradigm for balanced extracellular proteolysis during cell migration and morphogenesis
105. Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells
106. Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis
107. Angiogenesis in vitro: Cytokines interactions and balanced extracellular proteolysis
108. Hypoxia induces capillary network formation in cultured bovine pulmonary microvessel endothelial cells
109. Differential expression of osteopontin, PC4, and CEC5, a novel mRNA species, during in vitro angiogenesis
110. Mechanisms of angiogenesis
111. Vasculogenesis
112. Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies
113. Pieces of eight: Bioactive fragments of extracellular proteins as regulators of angiogenesis
114. Regulation of angiogenesis by extracellular matrix: The growth and the glue
115. Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals
116. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse
117. Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways
118. Paracrine or virus-mediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices
119. Effects of culture conditions on the proliferation, morphology and migration of bovine aortic endothelial cells
120. -/- embryonic stem cells and embryos
121. Failure of blood-island formation and vasculogenesis in flk-1 deficient mice
122. Thrombospondin-1, a natural inhibitor of angiogenesis, regulates platelet-endothelial cell adhesion molecule-1 expression and endothelial cell morphogenesis
123. Cell proliferation on fibrin: Modulation by fibrinopeptide cleavage
124. The role of NF-κB in the angiogenic response of coronary microvessel endothelial cells
125. Direct stimulation of limbal microvessel endothelial cell proliferation and capillary formation in vitro by a corneal-derived eicosanoid
126. PDGF-BB increases endothelial migration on cord movements during angiogenesis in vitro
127. Fibrin degradation and angiogenesis: Quantitative analysis of the angiogenic response in the chick chorioallantoic membrane
128. Endothelial metalloprotease-disintegrin protein (ADAM) is implicated in angiogenesis in vitro
129. Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro
130. The formation of tubular structures by endothelial cells is under the control of fibrinolysis and mechanical factors
131. Description of an in vitro angiogenesis model designed to test antiangiogenic molecules
132. In vitro angiogenesis is modulated by the mechanical properties of fibrin and is related to αv/β3 integrin localisation
133. Role of fibrin and plasminogen activators in repair-associated angiogenesis: In vitro studies with human endothelial cells
134. Oncostatin M induces angiogenesis in vitro and in vivo
135. Reorganization of basement membrane matrices by cellular traction promotes the formation of cellular networks in vitro
136. Organized type I collagen influences endothelial patterns during "spontaneous angiogenesis in vitro": Planar cultures as models of vascular development
137. Between molecules and morphology. Extracellular matrix and creation of vascular form
138. A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices
139. Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies
140. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps
141. Embryonic stem cell-derived cystic embryoid bodies form vascular channels: An in vitro model of blood vessel development
142. The embryoid body as a novel in vitro assay system for antiangiogenic agents
143. Induction of endothelial cell differentiation into capillary-like structures by substance P
144. Insulin stimulates the growth and tube formation of human microvascular endothelial growth factor
145. Advanced glycation end products-driven angiogenesis in vitro
146. Functional roles for PECAM-1 (CD31) and VE-Cadherin (CD144) in tube formation assembly and lumen formation in three-dimensional collagen gels
147. Vasculogenesis from embryonic bodies of murine embryonic stem cells transfected by TGF-β1 gene
148. Regulation of vascular growth and regression by matrix metalloproteinases in the rat aorta model of angiogenesis
149. Models of in vitro angiogenesis: Endothelial cell differentiation on fibrin but not Matrigel is transcriptionally dependent